Ajanta Pharma Limited
AJANTPHARM
Kedudukan dalam Saham
#3733
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Harga Saham
$35.95
Modal Pasaran
$4.49B
Perubahan (1 hari)
-1.24%
Perubahan (1 tahun)
29.30%
Negara
IN
Perdagangan Ajanta Pharma Limited (AJANTPHARM)
Kategori
Healthcare
Nisbah P/E bagi Ajanta Pharma Limited (AJANTPHARM)
Nisbah P/E pada October 2026 TTM: 36.76
Menurut laporan kewangan dan harga saham terkini Ajanta Pharma Limited, nisbah P/E semasa (TTM) ialah 36.76. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 34.54.
Sejarah nisbah P/E bagi Ajanta Pharma Limited dari 2005 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 36.76 | 3.26% |
| 2025 | 35.60 | 3.07% |
| 2024 | 34.54 | 31.12% |
| 2023 | 26.34 | 19.93% |
| 2022 | 21.96 | -7.97% |
| 2021 | 23.86 | -6.39% |
| 2020 | 25.49 | 8.31% |
| 2019 | 23.53 | -10.60% |
| 2018 | 26.33 | -13.88% |
| 2017 | 30.57 | -1.04% |
| 2016 | 30.89 | -11.43% |
| 2015 | 34.88 | 133.25% |
| 2014 | 14.95 | 9.27% |
| 2013 | 13.69 | 97.10% |
| 2012 | 6.94 | 50.18% |
| 2011 | 4.62 | -26.14% |
| 2010 | 6.26 | 165.04% |
| 2009 | 2.36 | -45.13% |
| 2008 | 4.30 | -24.79% |
| 2007 | 5.72 | -17.47% |
| 2006 | 6.93 | 2.48% |
| 2005 | 6.77 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | -4.90% |
IN
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.